276 related articles for article (PubMed ID: 6305079)
1. Comparison of oestrogen and GnRH agonist analogue-induced inhibition of the pituitary-testicular function in rat.
Huhtaniemi IT; Warren DD; Catt KJ
Acta Endocrinol (Copenh); 1983 Jun; 103(2):163-71. PubMed ID: 6305079
[TBL] [Abstract][Full Text] [Related]
2. Induction and maintenance of gonadotropin and lactogen receptors in hypoprolactinemic rats.
Huhtaniemi IT; Catt KJ
Endocrinology; 1981 Aug; 109(2):483-90. PubMed ID: 6265191
[TBL] [Abstract][Full Text] [Related]
3. Suppression of pituitary-testis function in rats treated neonatally with a gonadotrophin-releasing hormone agonist and antagonist: acute and long-term effects.
Kolho KL; Huhtaniemi I
J Endocrinol; 1989 Oct; 123(1):83-91. PubMed ID: 2509621
[TBL] [Abstract][Full Text] [Related]
4. Effects of gonadotropin-releasing hormone receptor blockade on rat testicular gonadotropin and lactogen receptors, steroidogenesis, and responses to human chorionic gonadotropin stimulation.
Huhtaniemi IT; Catt KJ
Endocrinology; 1985 Jan; 116(1):281-7. PubMed ID: 2981066
[TBL] [Abstract][Full Text] [Related]
5. The effect of the chronic administration of a potent luteinizing hormone releasing hormone analog on the rat prostate.
Trachtenberg J
J Urol; 1982 Nov; 128(5):1097-100. PubMed ID: 6294350
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone and its agonist inhibit testicular luteinizing hormone receptor and steroidogenesis in immature and adult hypophysectomized rats.
Bambino TH; Schreiber JR; Hsueh AJ
Endocrinology; 1980 Oct; 107(4):908-17. PubMed ID: 6250797
[TBL] [Abstract][Full Text] [Related]
7. Study of the direct action of luteinizing hormone-releasing hormone agonists at the testicular level in intact rats treated with an antiluteinizing hormone serum.
Séguin C; Bélanger A; Labrie F; Hansel W
Endocrinology; 1982 Feb; 110(2):524-30. PubMed ID: 6276140
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of pituitary-gonadal function in male rats by a potent GnRH antagonist.
Puente M; Catt KJ
J Steroid Biochem; 1986 Dec; 25(6):917-25. PubMed ID: 3025519
[TBL] [Abstract][Full Text] [Related]
9. Pituitary-testicular function in immature rats after treatment with GnRH antagonist, GnRH antiserum and bromocriptine.
Huhtaniemi IT; Stewart JM; Channabasavaiah K; Fraser HM; Clayton RN
Mol Cell Endocrinol; 1984 Feb; 34(2):137-43. PubMed ID: 6325270
[TBL] [Abstract][Full Text] [Related]
10. Regulation of infant and developing rat testicular gonadotropin and prolactin receptors and steroidogenesis by treatments with human chorionic gonadotropin, gonadotropin-releasing hormone analogs, bromocriptine, prolactin, and estrogen.
Huhtaniemi IT; Warren DW; Catt KJ
Biol Reprod; 1985 May; 32(4):721-32. PubMed ID: 2988657
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic D-Leu6, des-Gly10-gonadotropin releasing hormone ethylamide on male sex tissues.
Rajfer J; Heber D; Peng S; Swerdloff RS
Biol Reprod; 1984 Apr; 30(3):646-51. PubMed ID: 6426536
[TBL] [Abstract][Full Text] [Related]
12. Blockade of rat testicular gonadotropin releasing hormone (GnRH) receptors by infusion of a GnRH antagonist has no major effects of Leydig cell function in vivo.
Huhtaniemi IT; Nikula H; Detta A; Stewart JM; Clayton RN
Mol Cell Endocrinol; 1987 Feb; 49(2-3):89-97. PubMed ID: 3030856
[TBL] [Abstract][Full Text] [Related]
13. Effects of an LHRH agonist on endocrine function, LHRH receptor and LH/hCG receptor in the pituitary-gonadal axis of male rats.
Komatsu M; Iwahana H; Mitsuhashi S
Endocrinol Jpn; 1986 Apr; 33(2):185-95. PubMed ID: 3019649
[TBL] [Abstract][Full Text] [Related]
14. Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist.
Ward JA; Robinson J; Furr BJ; Shalet SM; Morris ID
Cancer Res; 1990 Feb; 50(3):568-74. PubMed ID: 2137024
[TBL] [Abstract][Full Text] [Related]
15. Absence of a direct inhibitory effect of the gonadotropin-releasing hormone (GnRH) agonist D-Ser (TBU)6, des-Gly-NH2(10) GnRH ethylamide (Buserelin) on testicular steroidogenesis in men.
Schaison G; Brailly S; Vuagnat P; Bouchard P; Milgrom E
J Clin Endocrinol Metab; 1984 May; 58(5):885-8. PubMed ID: 6423662
[TBL] [Abstract][Full Text] [Related]
16. Endocrinological studies on TAP-144-SR, a sustained-release formulation of a potent GnRH agonist (D-Leu6-[des-Gly10-NH2]-GnRH ethylamide), in male rats.
Sudo K; Masaki T; Shiota K; Kawase M; Fujita T
Endocrinol Jpn; 1990 Oct; 37(5):685-93. PubMed ID: 2128273
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone agonist analog-induced steroidogenic lesion in the neonatal rat testis: evidence for direct gonadal action.
Huhtaniemi IT; Clayton RN; Catt KJ
Endocrinology; 1984 Jul; 115(1):233-8. PubMed ID: 6329649
[TBL] [Abstract][Full Text] [Related]
18. Effect of treatment with an agonist of luteinizing hormone releasing hormone on early maturational changes in pituitary and testicular function in the rat.
Sharpe RM; Fraser HM; Sandow J
J Endocrinol; 1979 Feb; 80(2):249-57. PubMed ID: 374673
[TBL] [Abstract][Full Text] [Related]
19. Physiological role of putative testicular gonadotrophin releasing hormone (GnRH).
Clayton RN; Detta A; Nikula H; Huhtaniemi IT
Med Biol; 1986; 63(5-6):201-9. PubMed ID: 3010007
[TBL] [Abstract][Full Text] [Related]
20. Recovery of pituitary-gonadal function in male and female rats after prolonged administration of a potent antagonist of luteinizing hormone-releasing hormone (SB-75).
Bokser L; Srkalovic G; Szepeshazi K; Schally AV
Neuroendocrinology; 1991 Aug; 54(2):136-45. PubMed ID: 1662786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
